These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15453109)

  • 1. Monoamine oxidase inhibitors and subarachnoid hemorrhage.
    Kundhal PS; Sockalingam S; Krishnadev N; Demarchi R; Bhalerao S
    Can J Psychiatry; 2004 Aug; 49(8):573-4. PubMed ID: 15453109
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs.
    Blackwell B; Marley E; Price J; Taylor D
    Br J Psychiatry; 1967 Apr; 113(497):349-65. PubMed ID: 6034391
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe hypertension related to caffeinated coffee and tranylcypromine: a case report.
    van der Hoeven N; Visser I; Schene A; van den Born BJ
    Ann Intern Med; 2014 May; 160(9):657-8. PubMed ID: 24798537
    [No Abstract]   [Full Text] [Related]  

  • 4. Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome.
    Rim CL; Gitlin MJ
    J Clin Psychopharmacol; 2010 Aug; 30(4):470-1. PubMed ID: 20631570
    [No Abstract]   [Full Text] [Related]  

  • 5. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.
    Tulen JH; Volkers AC; van den Broek WW; Bruijn JA
    J Clin Psychopharmacol; 2006 Oct; 26(5):542-4. PubMed ID: 16974207
    [No Abstract]   [Full Text] [Related]  

  • 6. Not all monoamine oxidase inhibitors are created equal.
    Stewart JT
    J Am Geriatr Soc; 2007 Nov; 55(11):1890. PubMed ID: 17979910
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracranial haemorrhage in patients treated with monoamineoxidase inhibitors.
    De Villiers JC
    Br J Psychiatry; 1966 Feb; 112(483):109-18. PubMed ID: 5906469
    [No Abstract]   [Full Text] [Related]  

  • 8. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP; Gleiter CH; Möller HJ
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degraded protein-containing food and monoamine oxidase inhibitors.
    Lieb J
    Am J Psychiatry; 1977 Dec; 134(12):1444-5. PubMed ID: 920856
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversible Cerebral Vasoconstriction Syndrome and Monoamine Oxidase Inhibitors.
    Durmuş B; Osse RJ; Emmer B; van Kooten F
    Prim Care Companion CNS Disord; 2016 Dec; 18(6):. PubMed ID: 27922229
    [No Abstract]   [Full Text] [Related]  

  • 11. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adverse drug reactions in combined treatment with tricyclic antidepressants and monoamine oxidase inhibitors].
    von Oefele K; Grohmann R; Hippius H; Rüther E
    Nervenarzt; 1988 Feb; 59(2):118-23. PubMed ID: 3362260
    [No Abstract]   [Full Text] [Related]  

  • 13. Do antihypertensives make tranylcypromine safer? Three case reports.
    Taylor BP; Quitkin FM; McGrath PJ; Stewart JW
    J Clin Psychiatry; 2005 May; 66(5):657-8. PubMed ID: 15889959
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of interaction of monoamine oxidase inhibitors and epinephrine in an older patient.
    Thompson DS; Sweet RA; Marzula K; Peredes JC
    J Clin Psychopharmacol; 1997 Aug; 17(4):322-3. PubMed ID: 9241014
    [No Abstract]   [Full Text] [Related]  

  • 15. Tranylcypromine discontinuation symptoms and withdrawal delirium.
    Freudenmann RW; Baumgarten E; Hawlik AE; Schönfeldt-Lecuona C; Gahr M
    J Clin Psychopharmacol; 2013 Aug; 33(4):574-6. PubMed ID: 23771195
    [No Abstract]   [Full Text] [Related]  

  • 16. Intoxications with the monoamine oxidase inhibitor tranylcypromine: an analysis of fatal and non-fatal events.
    Gahr M; Schönfeldt-Lecuona C; Kölle MA; Freudenmann RW
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1364-72. PubMed ID: 23791433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant use of modafinil and tranylcypromine in a patient with narcolepsy: a case report.
    Clemons WE; Makela E; Young J
    Sleep Med; 2004 Sep; 5(5):509-11. PubMed ID: 15341899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Spontaneous' hypertensive episodes with monoamine oxidase inhibitors.
    Fallon B; Foote B; Walsh BT; Roose SP
    J Clin Psychiatry; 1988 Apr; 49(4):163-5. PubMed ID: 3281932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH; Baxter LR; Rego J
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Elderly patients, classical monoamine oxidase inhibitors and intercurrent somatic diseases].
    Oostervink F; Bouvy PF; Touw DJ
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1937-40. PubMed ID: 14574773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.